Age-Related Macular Degeneration: Insights into Inflammatory Genes

Journal of Ophthalmology

Volumn 2014, Issue , 2014, Pages

  Cascella, Raffaella ^a   Ragazzo, Michele ^a   Strafella, Claudia ^a   Missiroli, Filippo ^b   Borgiani, Paola ^a   Angelucci, Francesco ^c   Marsella, Luigi Tonino ^a   Cusumano, Andrea ^b   Novelli, Giuseppe ^a   Ricci, Federico ^b   Giardina, Emiliano ^a,c  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

^c IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84912058346     PISSN: 2090004X     EISSN: 20900058     Source Type: Journal    
DOI: 10.1155/2014/582842     Document Type: Review

References (117)

1. Seddon J. M., Sobrin L., Albert D., Miller J., Azar D., Blodi B., Epidemiology of age-related macular degeneration. Albert & Jakobiec's Principles and Practice of Ophthalmology 2007 Philadelphia, Pa, USA Saunders 413 422
2. Swaroop A., Chew E. Y., Rickman C. B., Abecasis G. R., Unraveling a multifactorial late-onset disease: from genetic susceptibility to disease mechanisms for age-related macular degeneration. Annual Review of Genomics and Human Genetics 2009 10 19 43 10.1146/annurev.genom.9.081307.164350 2-s2.0-70350238360
3. Ke K. M., The direct, indirect and intangible costs of visual impairment caused by neovascular age-related macular degeneration. European Journal of Health Economics 2010 11 6 525 531 10.1007/s10198-009-0207-9 2-s2.0-78649906573
4. Lim L. S., Mitchell P., Seddon J. M., Holz F. G., Wong T. Y., Age-related macular degeneration. The Lancet 2012 379 9827 1728 1738 10.1016/S0140-6736(12)60282-7 2-s2.0-84860511567
5. Gopinath B., Liew G., Burlutsky G., Mitchell P., Age-related macular degeneration and 5-year incidence of impaired activities of daily living. Maturitas 2014 77 3 263 266 10.1016/j.maturitas.2013.12.001 2-s2.0-84896710756
6. Wong W. L., Su X., Li X., Cheung C. M. G., Klein R., Cheng C.-Y., Wong T. Y., Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. The Lancet Global Health 2014 2 2 e106 e116 10.1016/S2214-109X(13)70145-1 2-s2.0-84892965801
7. World Health Organization, VISION 2020: the Right to Sight, the global initiative for the elimination of avoidable blindness: magnitude and causes of visual impairment. Fact Sheet 2004 282
8. Augood C. A., Vingerling J. R., de Jong P. T. V. M., Prevalence of age-related maculopathy in older Europeans: the European Eye Study (EUREYE). Archives of Ophthalmology 2006 124 4 529 535 10.1001/archopht.124.4.529 2-s2.0-33645890840
9. Mullins R. F., Russell S. R., Anderson D. H., Hageman G. S., Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. The FASEB Journal 2000 14 7 835 846 2-s2.0-0034012166
10. Van Leeuwen R., Klaver C. C. W., Vingerling J. R., Hofman A., De Jong P. T. V. M., Epidemiology of age-related maculopathy: a review. European Journal of Epidemiology 2003 18 9 845 854 10.1023/A:1025643303914 2-s2.0-0141681329
11. Hageman G. S., Luthert P. J., Victor Chong N. H., Johnson L. V., Anderson D. H., Mullins R. F., An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Progress in Retinal and Eye Research 2001 20 6 705 732 10.1016/S1350-9462(01)00010-6 2-s2.0-0034832029
12. Anderson D. H., Mullins R. F., Hageman G. S., Johnson L. V., A role for local inflammation in the formation of drusen in the aging eye. American Journal of Ophthalmology 2002 134 3 411 431 2-s2.0-0036741098 10.1016/S0002-9394(02)01624-0
13. Bok D., Evidence for an inflammatory process in age-related macular degeneration gains new support. Proceedings of the National Academy of Sciences of the United States of America 2005 102 20 7053 7054 10.1073/pnas.0502819102 2-s2.0-18844453162
14. Spraul C. W., Lang G. E., Grossniklaus H. E., Morphometric analysis of the choroid, Bruch's membrane, and retinal pigment epithelium in eyes with age-related macular degeneration. Investigative Ophthalmology and Visual Science 1996 37 13 2724 2735 2-s2.0-0030471907
15. Green W. R., Histopathology of age-related macular degeneration. Molecular vision 1999 5, article 27 2-s2.0-0033520641
16. Algvere P. V., Seregard S., Drusen maculopathy: a risk factor for AMD. Can we prevent visual loss? Acta Ophthalmologica Scandinavica 2003 81 5 427 429 10.1034/j.1600-0420.2003.00157.x 2-s2.0-0142029600
17. Friberg T. R., Bilonick R. A., Brennen P. M., Risk factors for conversion to neovascular age-related macular degeneration based on longitudinal morphologic and visual acuity data. Ophthalmology 2012 119 7 1432 1437 10.1016/j.ophtha.2012.02.048 2-s2.0-84863326306
18. Smith W., Assink J., Klein R., Risk factors for age-related macular degeneration: pooled findings from three continents. Ophthalmology 2001 108 4 697 704 2-s2.0-0035078715 10.1016/S0161-6420(00)00580-7
19. National Eye Institute, Age-Related Macular Degeneration (AMD) 2014 National Eye Institute
20. Velilla S., García-Medina J. J., García-Layana A., Dolz-Marco R., Pons-Vázquez S., Pinazo-Durán M. D., Gómez-Ulla F., Arévalo J. F., Díaz-Llopis M., Gallego-Pinazo R., Smoking and age-related macular degeneration: review and update. Journal of Ophthalmology 2013 2013 11 895147 10.1155/2013/895147 2-s2.0-84893827125
21. Curcio C. A., Owsley C., Jackson G. R., Spare the rods, save the cones in aging and age-related maculopathy. Investigative Ophthalmology and Visual Science 2000 41 8 2015 2018 2-s2.0-0033924382
22. Fowles J., Dybing E., Application of toxicological risk assessment principles to the chemical constituents of cigarette smoke. Tobacco Control 2003 12 4 424 430 10.1136/tc.12.4.424 2-s2.0-4143062086
23. Roth F., Bindewald A., Holz F. G., Keypathophysiologic pathways in age-related macular disease. Graefe's Archive for Clinical and Experimental Ophthalmology 2004 242 8 710 716 10.1007/s00417-004-0976-x 2-s2.0-4544273293
24. Benowitz N. L., Cigarette smoking and cardiovascular disease: pathophysiology and implications for treatment. Progress in Cardiovascular Diseases 2003 46 1 91 111 10.1016/S0033-0620(03)00087-2 2-s2.0-0041967223
25. Deisinger P. J., Hill T. S., English J. C., Human exposure to naturally occurring hydroquinone. Journal of Toxicology and Environmental Health Part A 1996 47 1 31 46 2-s2.0-0030068243 10.1080/009841096161915
26. DeCaprio A. P., The toxicology of hydroquinone-relevance to occupational and environmental exposure. Critical Reviews in Toxicology 1999 29 3 283 330 10.1080/10408449991349221 2-s2.0-0033022871
27. Zampatti S., Ricci F., Cusumano A., Marsella L. T., Novelli G., Giardina E., Review of nutrient actions on age-related macular degeneration. Nutrition Research 2014 34 2 95 105 10.1016/j.nutres.2013.10.011 2-s2.0-84892852832
28. Klein B. E. K., Knudtson M. D., Lee K. E., Reinke J. O., Danforth L. G., Wealti A. M., Moore E., Klein R., Supplements and age-related eye conditions the beaver dam eye study. Ophthalmology 2008 115 7 1203 1208 10.1016/j.ophtha.2007.09.011 2-s2.0-45849152116
29. SanGiovanni J. P., Chew E. Y., Clemons T. E., Ferris F. L. III, Gensler G., Lindblad A. S., Milton R. C., Seddon J. M., Sperduto R. D., The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study: AREDS report No. 22. Archives of Ophthalmology 2007 125 9 1225 1232 10.1001/archopht.125.9.1225 2-s2.0-34548650913
30. Evans J. R., Lawrenson J. G., Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration. Cochrane Database of Systematic Reviews 2012 6 CD000253 2-s2.0-84873038306
31. Chong E. W.-T., Wong T. Y., Kreis A. J., Simpson J. A., Guymer R. H., Dietary antioxidants and primary prevention of age related macular degeneration: systematic review and meta-analysis. British Medical Journal 2007 335 7623 755 759 10.1136/bmj.39350.500428.47 2-s2.0-35348966298
32. Millen A. E., Voland R., Sondel S. A., Parekh N., Horst R. L., Wallace R. B., Hageman G. S., Chappell R., Blodi B. A., Klein M. L., Gehrs K. M., Sarto G. E., Mares J. A., Vitamin D status and early age-related macular degeneration in postmenopausal women. Archives of Ophthalmology 2011 129 4 481 489 10.1001/archophthalmol.2011.48 2-s2.0-79953838872
33. Christen W. G., Glynn R. J., Chew E. Y., Albert C. M., Manson J. E., Folic acid, pyridoxine, and cyanocobalamin combination treatment and age-related macular degeneration in women: the women's antioxidant and folic acid cardiovascular study. Archives of Internal Medicine 2009 169 4 335 341 10.1001/archinternmed.2008.574 2-s2.0-61549126593
34. Kuzniarz M., Mitchell P., Flood V. M., Wang J. J., Use of vitamin and zinc supplements and age-related maculopathy: the Blue Mountains Eye Study. Ophthalmic Epidemiology 2002 9 4 283 295 10.1076/opep.9.4.283.1511 2-s2.0-0036021773
35. Seddon J. M., Cote J., Page W. F., Aggen S. H., Neale M. C., The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences. Archives of Ophthalmology 2005 123 3 321 327 10.1001/archopht.123.3.321 2-s2.0-14944364782
36. Hammond C. J., Webster A. R., Snieder H., Bird A. C., Gilbert C. E., Spector T. D., Genetic influence on early age-related maculopathy: a twin study. Ophthalmology 2002 109 4 730 736 10.1016/S0161-6420(01)01049-1 2-s2.0-0036211136
37. Scholl H. P. N., Fleckenstein M., Issa P. C., Keilhauer C., Holz F. G., Weber B. H. F., An update on the genetics of age-related macular degeneration. Molecular Vision 2007 13 196 205 2-s2.0-33846935944
38. Klaver C. C. W., Assink J. J. M., Van Leeuwen R., Wolfs R. C. W., Vingerling J. R., Stijnen T., Hofman A., De Jong P. T. V. M., Incidence and progression rates of age-related maculopathy: the Rotterdam Study. Investigative Ophthalmology and Visual Science 2001 42 10 2237 2241 2-s2.0-0034852996
39. Swaroop A., Branham K. E. H., Chen W., Abecasis G., Genetic susceptibility to age-related macular degeneration: a paradigm for dissecting complex disease traits. Human Molecular Genetics 2007 16 2 174 182 10.1093/hmg/ddm212 2-s2.0-38449106206
40. Klein R. J., Zeiss C., Chew E. Y., Complement factor H polymorphism in age-related macular degeneration. Science 2005 308 5720 385 389 10.1126/science.1109557 2-s2.0-20244380171
41. Edwards A. O., Ritter R. III, Abel K. J., Manning A., Panhuysen C., Farrer L. A., Complement factor H polymorphism and age-related macular degeneration. Science 2005 308 5720 421 424 10.1126/science.1110189 2-s2.0-17244379811
42. Haines J. L., Hauser M. A., Schmidt S., Scott W. K., Olson L. M., Gallins P., Spencer K. L., Shu Y. K., Noureddine M., Gilbert J. R., Schnetz-Boutaud N., Agarwal A., Postel E. A., Pericak-Vance M. A., Complement factor H variant increases the risk of age-related macular degeneration. Science 2005 308 5720 419 421 2-s2.0-20244388812 10.1126/science.1110359
43. Zareparsi S., Branham K. E. H., Li M., Strong association of the Y402H variant in complement factor H at 1q32 with susceptibility to age-related macular degeneration. The American Journal of Human Genetics 2005 77 1 149 153 2-s2.0-20544471911 10.1086/431426
44. Jakobsdottir J., Conley Y. P., Weeks D. E., Mah T. S., Ferrell R. E., Gorin M. B., Susceptibility genes for age-related maculopathy on chromosome 10q26. The American Journal of Human Genetics 2005 77 3 389 407 10.1086/444437 2-s2.0-23944465880
45. Rivera A., Fisher S. A., Fritsche L. G., Keilhauer C. N., Lichtner P., Meitinger T., Weber B. H. F., Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. Human Molecular Genetics 2005 14 21 3227 3236 10.1093/hmg/ddi353 2-s2.0-27744462212
46. Schmidt S., Hauser M. A., Scott W. K., Postel E. A., Agarwal A., Gallins P., Wong F., Chen Y. S., Spencer K., Schnetz-Boutaud N., Haines J. L., Pericak-Vance M. A., Cigarette smoking strongly modifies the association of LOC387715 and age-related macular degeneration. The American Journal of Human Genetics 2006 78 5 852 864 10.1086/503822 2-s2.0-33646070308
47. Fritsche L. G., Loenhardt T., Janssen A., Fisher S. A., Rivera A., Keilhauer C. N., Weber B. H. F., Age-related macular degeneration is associated with an unstable ARMS2 (LOC387715) mRNA. Nature Genetics 2008 40 7 892 896 2-s2.0-46249098503 10.1038/ng.170
48. Fritsche L. G., Chen W., Schu M., Seven new loci associated with age-related macular degeneration. Nature Genetics 2013 45 4 433 439
49. Whitcup S. M., Sodhi A., Atkinson J. P., Holers V. M., Sinha D., Rohrer B., Dick A. D., The role of the immune response in age-related macular degeneration. International Journal of Inflammation 2013 2013 10 348092 10.1155/2013/348092 2-s2.0-84878684237
50. Ambati J., Atkinson J. P., Gelfand B. D., Immunology of age-related macular degeneration. Nature Reviews Immunology 2013 13 6 438 451 2-s2.0-84878214672 10.1038/nri3459
51. Ozaki E., Campbell M., Kiang A. S., Inflammation in age-related macular degeneration. Advances in Experimental Medicine and Biology 2014 801 229 235
52. Forrester J. V., Bowman lecture on the role of inflammation in degenerative disease of the eye. Eye 2013 27 3 340 352 2-s2.0-84875137211 10.1038/eye.2012.265
53. Ansar W., Ghosh S., C-reactive protein and the biology of disease. Immunologic Research 2013 56 1 131 142 10.1007/s12026-013-8384-0 2-s2.0-84876418473
54. Virdis A., Dell'Agnello U., Taddei S., Impact of inflammation on vascular disease in hypertension. Maturitas 2014 78 3 179 183 2-s2.0-84900377917 10.1016/j.maturitas.2014.04.012
55. Novelli G., Borgiani P., Giardina E., Mango R., Contino G., Romeo F., Mehta J. L., Role of genetics in prevention of coronary atherosclerosis. Current Opinion in Cardiology 2003 18 5 368 371 10.1097/00001573-200309000-00008 2-s2.0-0141788069
56. Giardina E., Sinibaldi C., Novelli G., The psoriasis genetics as a model of complex disease. Current Drug Targets: Inflammation and Allergy 2004 3 2 129 136 10.2174/1568010043343877 2-s2.0-3042646567
57. Maru G. B., Gandhi K., Ramchandani A., Kumar G., The role of inflammation in skin cancer. Advances in Experimental Medicine and Biology 2014 816 437 469
58. Bonomi M., Patsias A., Posner M., Sikora A., The role of inflammation in head and neck cancer. Advances in Experimental Medicine and Biology 2014 816 107 127 10.1007/978-3-0348-0837-8-5
59. Libby P., Inflammatory mechanisms: the molecular basis of inflammation and disease. Nutrition Reviews 2007 65 3 S140 S146 10.1111/j.1753-4887.2007.tb00352.x 2-s2.0-39649083371
60. Hansson G. K., Libby P., Schönbeck U., Yan Z.-Q., Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circulation Research 2002 91 4 281 291 2-s2.0-0037163149 10.1161/01.RES.0000029784.15893.10
61. Turner M. D., Nedjai B., Hurst T., Pennington D. J., Cytokines and chemokines: at the crossroads of cell signalling and inflammatory disease. Biochimica et Biophysica Acta-Molecular Cell Research 2014 1843 11 2563 2582 10.1016/j.bbamcr.2014.05.014
62. Janeway C. A. Jr., Medzhitov R., Innate immune recognition. Annual Review of Immunology 2002 20 197 216 10.1146/annurev.immunol.20.083001.084359 2-s2.0-0036212849
63. Medzhitov R., Janeway C. Jr., Innate immunity. The New England Journal of Medicine 2000 343 5 338 344 10.1056/NEJM200008033430506
64. Lamkanfi M., Dixit V. M., Mechanisms and functions of inflammasomes. Cell 2014 157 5 1013 1022 10.1016/j.cell.2014.04.007 2-s2.0-84901310586
65. Libby P., Inflammation and cardiovascular disease mechanisms. The American Journal of Clinical Nutrition 2006 83 2 456S 460S 2-s2.0-33644872836
66. Nuzzo D., Picone P., Caruana L., Vasto S., Barera A., Caruso C., Di Carlo M., Inflammatory mediators as biomarkers in brain disorders. Inflammation 2014 37 3 639 648 10.1007/s10753-013-9780-2 2-s2.0-84888236840
67. Wong-Riley M. T., Energy metabolism of the visual system. Journal of Eye and Brain 2010 2 99 116
68. Chen M., Forrester J. V., Xu H., Dysregulation in retinal para-inflammation and age-related retinal degeneration in CCL2 or CCR2 deficient mice. PLoS ONE 2011 6 8 e22818 2-s2.0-79961159284 10.1371/journal.pone.0022818
69. Harman D., About "origin and evolution of the free radical theory of aging: a brief personal history, 1954-2009" Biogerontology 2009 10 6 783 2-s2.0-71349088664 10.1007/s10522-009-9253-z
70. Bank S., Andersen P. S., Burisch J., Polymorphisms in the inflammatory pathway genes TLR2, TLR4, TLR9, LY96, NFKBIA, NFKB1, TNFA, TNFRSF1A, IL6R, IL10, IL23R, PTPN22, and PPARG are associated with susceptibility of inflammatory bowel disease in a danish cohort. PLoS ONE 2014 9 6 e98815 10.1371/journal.pone.0098815
71. Adami S., Cavani A., Rossi F., Girolomoni G., The role of interleukin-17A in psoriatic disease. BioDrugs 2014 10.1007/s40259-014-0098-x 2-s2.0-84901583187
72. Seddon J. M., George S., Rosner B., Rifai N., Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers. Archives of Ophthalmology 2005 123 6 774 782 10.1001/archopht.123.6.774 2-s2.0-20644467790
73. Goverdhan S. V., Ennis S., Hannan S. R., Interleukin-8 promoter polymorphism -251A/T is a risk factor for age-related macular degeneration. British Journal of Ophthalmology 2008 92 4 537 540 2-s2.0-41849107208 10.1136/bjo.2007.123190
74. Tsai Y.-Y., Lin J.-M., Wan L., Lin H.-J., Lee C.-C., Tsai C.-H., Tsai F.-J., Tseng S.-H., Interleukin gene polymorphisms in age-related macular degeneration. Investigative Ophthalmology and Visual Science 2008 49 2 693 698 10.1167/iovs.07-0125 2-s2.0-40649097084
75. Garlanda C., Dinarello C. A., Mantovani A., The interleukin-1 family: back to the future. Immunity 2013 39 6 1003 1018 2-s2.0-84890235827 10.1016/j.immuni.2013.11.010
76. Fishman D., Faulds G., Jeffey R., Mohamed-Ali V., Yudkin J. S., Humphries S., Woo P., The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. The Journal of Clinical Investigation 1998 102 7 1369 1376 10.1172/JCI2629 2-s2.0-0032189103
77. Holmes W. E., Lee J., Kuang W.-J., Rice G. C., Wood W. I., Structure and functional expression of a human interleukin-8 receptor. Science 1991 253 5025 1278 1280 10.1126/science.1840701 2-s2.0-0026095795
78. Murphy P. M., Tiffany H. L., Cloning of complementary DNA encoding a functional human interleukin-8 receptor. Science 1991 253 5025 1280 1283 10.1126/science.1891716 2-s2.0-0026018108
79. Gao L.-B., Pan X.-M., Jia J., Liang W.-B., Rao L., Xue H., Zhu Y., Li S.-L., Lv M.-L., Deng W., Chen T.-Y., Wei Y.-G., Zhang L., IL-8 -251A/T polymorphism is associated with decreased cancer risk among population-based studies: Evidence from a meta-analysis. European Journal of Cancer 2010 46 8 1333 1343 2-s2.0-77951667554 10.1016/j.ejca.2010.03.011
80. Tsai Y.-Y., Lin J.-M., Wan L., Interleukin gene polymorphisms in age-related macular degeneration. Investigative Ophthalmology & Visual Science 2008 49 2 693 698 10.1167/iovs.07-0125 2-s2.0-40649097084
81. Simonini A., Moscucci M., Muller D. W. M., Bates E. R., Pagani F. D., Burdick M. D., Strieter R. M., IL-8 is an angiogenic factor in human coronary atherectomy tissue. Circulation 2000 101 13 1519 1526 10.1161/01.CIR.101.13.1519 2-s2.0-0034603748
82. Ricci F., Staurenghi G., Lepre T., Missiroli F., Zampatti S., Cascella R., Borgiani P., Marsella L. T., Eandi C. M., Cusumano A., Novelli G., Giardina E., Haplotypes in IL-8 gene are associated to age-related macular degeneration: a case-control study. PLoS ONE 2013 8 6 e66978 10.1371/journal.pone.0066978 2-s2.0-84879224300
83. Mélik-Parsadaniantz S., Rostène W., Chemokines and neuromodulation. Journal of Neuroimmunology 2008 198 1-2 62 68 2-s2.0-47249163193 10.1016/j.jneuroim.2008.04.022
84. Colobran R., Pedrosa E., Carretero-Iglesia L., Juan M., Copy number variation in chemokine superfamily: the complex scene of CCL3L-CCL4L genes in health and disease. Clinical & Experimental Immunology 2010 162 1 41 52 10.1111/j.1365-2249.2010.04224.x 2-s2.0-77956545747
85. Sharma N. K., Gupta A., Prabhakar S., Singh R., Bhatt A. K., Anand A., CC chemokine receptor-3 as new target for age-related macular degeneration. Gene 2013 523 1 106 111 2-s2.0-84877835084 10.1016/j.gene.2013.03.052
86. Takeda A., Baffi J. Z., Kleinman M. E., CCR3 is a target for age-related macular degeneration diagnosis and therapy. Nature 2009 460 7252 225 230 10.1038/nature08151 2-s2.0-67650457597
87. Parmeggiani F., Sorrentino F. S., Romano M. R., Costagliola C., Semeraro F., Incorvaia C., D'Angelo S., Perri P., De Nadai K., Bonomo Roversi E., Franceschelli P., Sebastiani A., Rubini M., Mechanism of inflammation in age-related macular degeneration: an up-to-date on genetic landmarks. Mediators of Inflammation 2013 2013 13 435607 2-s2.0-84893862245 10.1155/2013/435607
88. Trouw L. A., Daha M. R., Role of complement in innate immunity and host defense. Immunology Letters 2011 138 1 35 37 10.1016/j.imlet.2011.02.014 2-s2.0-79957765079
89. Klein R., Myers C. E., Cruickshanks K. J., Gangnon R. E., Danforth L. G., Sivakumaran T. A., Iyengar S. K., Tsai M. Y., Klein B. E. K., Markers of inflammation, oxidative stress, and endothelial dysfunction and the 20-year cumulative incidence of early age-related macular degeneration the beaver dam eye study. JAMA Ophthalmology 2014 132 4 446 455 2-s2.0-84898639156 10.1001/jamaophthalmol.2013.7671
90. Schramm E. C., Clark S. J., Triebwasser M. P., Genetic variants in the complement system predisposing to age-related macular degeneration: a review. Molecular Immunology 2014 5890 14 161 163
91. MacHalińska A., Kawa M. P., Marlicz W., MacHaliński B., Complement system activation and endothelial dysfunction in patients with age-related macular degeneration (AMD): possible relationship between AMD and atherosclerosis. Acta Ophthalmologica 2012 90 8 695 703 10.1111/j.1755-3768.2011.02295.x 2-s2.0-84870549384
92. Clark S. J., Bishop P. N., Day A. J., Complement factor H and age-related macular degeneration: the role of glycosaminoglycan recognition in disease pathology. Biochemical Society Transactions 2010 38 5 1342 1348 10.1042/BST0381342 2-s2.0-77957271118
93. Donoso L. A., Vrabec T., Kuivaniemi H., The role of complement factor H in age-related macular degeneration: a review. Survey of Ophthalmology 2010 55 3 227 246 2-s2.0-77951477731 10.1016/j.survophthal.2009.11.001
94. Despriet D. D. G., Klaver C. C. W., Witteman J. C. M., Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration. The Journal of the American Medical Association 2006 296 3 301 309 10.1001/jama.296.3.301 2-s2.0-33746041795
95. Ricci F., Zampatti S., D'Abbruzzi F., Typing of ARMS2 and CFH in age-related macular degeneration: case-control study and assessment of frequency in the Italian population. Archives of Ophthalmology 2009 127 10 1368 1372 2-s2.0-70350710243 10.1001/archophthalmol.2009.237
96. Seddon J. M., Yu Y., Miller E. C., Reynolds R., Tan P. L., Gowrisankar S., Goldstein J. I., Triebwasser M., Anderson H. E., Zerbib J., Kavanagh D., Souied E., Katsanis N., Daly M. J., Atkinson J. P., Raychaudhuri S., Rare variants in CFI, C3 and C9 are associated with high risk of advanced age-related macular degeneration. Nature Genetics 2013 45 11 1366 1373 2-s2.0-84887080613 10.1038/ng.2741
97. Thakkinstian A., McEvoy M., Chakravarthy U., Chakrabarti S., McKay G. J., Ryu E., Silvestri G., Kaur I., Francis P., Iwata T., Akahori M., Arning A., Edwards A. O., Seddon J. M., Attia J., The association between complement component 2/complement factor B polymorphisms and age-related macular degeneration: a HuGE review and meta-analysis. American Journal of Epidemiology 2012 176 5 361 372 10.1093/aje/kws031 2-s2.0-84865776603
98. Sun C., Zhao M., Li X., CFB/C2 gene polymorphisms and risk of age-related macular degeneration: a systematic review and meta-analysis. Current Eye Research 2012 37 4 259 271 10.3109/02713683.2011.635401 2-s2.0-84859024248
99. Seddon J. M., Reynolds R., Maller J., Fagerness J. A., Daly M. J., Rosner B., Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables. Investigative Ophthalmology and Visual Science 2009 50 5 2044 2053 2-s2.0-65549129157 10.1167/iovs.08-3064
100. Markiewski M. M., Lambris J. D., The role of complement in inflammatory diseases from behind the scenes into the spotlight. American Journal of Pathology 2007 171 3 715 727 2-s2.0-34548849117 10.2353/ajpath.2007.070166
101. Wang G., Spencer K. L., Scott W. K., Whitehead P., Court B. L., Ayala-Haedo J., Mayo P., Schwartz S. G., Kovach J. L., Gallins P., Polk M., Agarwal A., Postel E. A., Haines J. L., Pericak-Vance M. A., Analysis of the indel at the ARMS2 3′UTR in age-related macular degeneration. Human Genetics 2010 127 5 595 602 2-s2.0-77951636898 10.1007/s00439-010-0805-8
102. Kanda A., Chen W., Othman M., Branham K. E. H., Brooks M., Khanna R., He S., Lyons R., Abecasis G. R., Swaroop A., A variant of mitochondrial protein LOC387715/ARMS2, not HTRA1, is strongly associated with age-related macular degeneration. Proceedings of the National Academy of Sciences of the United States of America 2007 104 41 16227 16232 10.1073/pnas.0703933104 2-s2.0-36049042661
103. Wang G., Spencer K. L., Court B. L., Olson L. M., Scott W. K., Haines J. L., Pericak-Vance M. A., Localization of age-related macular degeneration-associated ARMS2 in cytosol, not mitochondria. Investigative Ophthalmology and Visual Science 2009 50 7 3084 3090 10.1167/iovs.08-3240 2-s2.0-67649998898
104. Wang G., Spencer K. L., Scott W. K., Whitehead P., Court B. L., Ayala-Haedo J., Mayo P., Schwartz S. G., Kovach J. L., Gallins P., Polk M., Agarwal A., Postel E. A., Haines J. L., Pericak-Vance M. A., Analysis of the indel at the ARMS2 3′UTR in age-related macular degeneration. Human Genetics 2010 127 5 595 602 2-s2.0-77951636898 10.1007/s00439-010-0805-8
105. Yasuma T. R., Nakamura M., Nishiguchi K. M., Kikuchi M., Kaneko H., Niwa T., Hamajima N., Terasaki H., Elevated c-reactive protein levels and ARMS2/HTRA1 gene variants in subjects without age-related macular degeneration. Molecular Vision 2010 16 2923 2930 2-s2.0-79551699589
106. Seddon J. M., Gensler G., Rosner B., C-reactive protein and CFH, ARMS2/HTRA1 gene variants are independently associated with risk of macular degeneration. Ophthalmology 2010 117 8 1560 1566 10.1016/j.ophtha.2009.11.020 2-s2.0-77955473846
107. Zeng F., Zhang M., Xu Y., Xu H., ARMS2 interference leads to decrease of proinflammatory mediators. Graefe's Archive for Clinical and Experimental Ophthalmology 2013 251 11 2539 2544 10.1007/s00417-013-2442-0 2-s2.0-84887153666
108. Campbell M., Doyle S. L., An eye on the future of inflammasomes and drug development in AMD. Journal of Molecular Medicine 2013 91 9 1059 1070 2-s2.0-84884290172 10.1007/s00109-013-1050-0
109. Dowling J. K., O'Neill L. A. J., Biochemical regulation of the inflammasome. Critical Reviews in Biochemistry and Molecular Biology 2012 47 5 424 443 10.3109/10409238.2012.694844 2-s2.0-84865510453
110. Masters S. L., O'Neill L. A. J., Disease-associated amyloid and misfolded protein aggregates activate the inflammasome. Trends in Molecular Medicine 2011 17 5 276 282 10.1016/j.molmed.2011.01.005 2-s2.0-79955156438
111. Schroder K., Zhou R., Tschopp J., The NLRP3 inflammasome: a sensor for metabolic danger? Science 2010 327 5963 296 300 2-s2.0-74549184092 10.1126/science.1184003
112. Kauppinen A., Niskanen H., Suuronen T., Kinnunen K., Salminen A., Kaarniranta K., Oxidative stress activates NLRP3 inflammasomes in ARPE-19 cells-implications for age-related macular degeneration (AMD). Immunology Letters 2012 147 1-2 29 33 2-s2.0-84865369140 10.1016/j.imlet.2012.05.005
113. Anderson O. A., Finkelstein A., Shima D. T., A2E induces IL-1 β production in retinal pigment epithelial cells via the NLRP3 inflammasome. PLoS ONE 2013 8 6 e67263 10.1371/journal.pone.0067263 2-s2.0-84879540747
114. Liu R. T., Gao J., Cao S., Sandhu N., Cui J. Z., Chou C. L., Fang E., Matsubara J. A., Inflammatory mediators induced by amyloid-beta in the retina and RPE in vivo: implications for inflammasome activation in age-related macular degeneration. Investigative Ophthalmology and Visual Science 2013 54 3 2225 2237 2-s2.0-84875661147 10.1167/iovs.12-10849
115. Tseng W. A., Thein T., Kinnunen K., Lashkari K., Gregory M. S., D'Amore P. A., Ksander B. R., NLRP3 inflammasome activation in retinal pigment epithelial cells by lysosomal destabilization: implications for age-related macular degeneration. Investigative Ophthalmology and Visual Science 2013 54 1 110 120 10.1167/iovs.12-10655 2-s2.0-84874524481
116. Ehrlich R., Harris A., Kheradiya N. S., Winston D. M., Ciulla T. A., Wirostko B., Age-related macular degeneration and the aging eye. Clinical Interventions in Aging 2008 3 3 473 482 2-s2.0-54949139970
117. Hyman L., Neborsky R., Risk factors for age-related macular degeneration: an update. Current Opinion in Ophthalmology 2002 13 3 171 175 10.1097/00055735-200206000-00007 2-s2.0-0036097438